What Is Plasma? From Physics to Skin Biology
Plasma, the fourth state of matter, forms when a gas becomes ionised: atoms lose electrons, creating a conductive gas cloud containing positive ions and free electrons. Plasma pen devices generate this plasma state instantaneously by creating a high-voltage electrical discharge between the metal probe and the skin surface.
When the probe is held approximately 1β2 mm from the skin without contact, the resulting "plasma arc" delivers highly controlled, localised thermal energy to the skin surface. At the point of contact, this energy forms a small "carbon dot" (eschar), instantly contracting and tightening the epidermis and upper dermis. Surrounding tissue is not heated β this feature is the most important mechanism strengthening the safety profile of plasma treatment.
Fibroblast Activation: The Biological Mechanism of Plasma Pen
The effects of plasma pen on the skin occur in two phases:
- Immediate mechanical tightening: Thermal energy instantly contracts and tightens skin tissue. This immediate effect is especially visible in lax areas such as the eyelids. Thermal contraction of collagen fibrils reduces the surface area and draws the skin taut.
- Delayed biostimulation: The controlled thermal injury activates dermal fibroblasts. Fibroblasts release growth factors such as TGF-Ξ², PDGF and EGF, initiating synthesis of collagen types I and III and elastin. This process is completed within 4β12 weeks; lasting tightening develops in a delayed fashion.
The healing cascade is divided into three phases: the inflammatory phase (first 72 hours), the proliferative phase (days 3β21) and the remodelling phase (3β12 months). During this final phase, collagen fibres reorganise; results continue to improve over time.
Treatment Indications for Plasma Pen
While plasma pen has a wide range of indications, the strongest evidence and clinical efficacy are concentrated in specific areas:
| Treatment Area | Clinical Goal | Evidence Level / Efficacy |
|---|---|---|
| Upper eyelid laxity (non-surgical blepharoplasty) | Skin tightening, correction of lid ptosis | High; surgical-grade result in mild to moderate laxity |
| Lower eyelid laxity | Lower lid tightening, reduction of under-eye wrinkles | Moderate; careful technique required (ectropion risk) |
| Perioral wrinkles (barcode lines) | Reduction of vertical perioral lines | Moderate to high; optimal in combination with laser |
| Neck and dΓ©colletΓ© sagging | Tightening of the platysma region | Moderate; multiple sessions required for larger areas |
| Forehead lines and brow lifting | Non-surgical brow lift effect | Moderate; combination with BTX improves results |
| Acne scars and depressed scars | Focal tightening, reduction of scar depth | Moderate; strong in combination with microneedling |
| Fibromas, warts, seborrhoeic keratosis | Lesion ablation / excision | High; may replace surgical excision |
| Xanthelasma (periorbital cholesterol deposits) | Ablation of cholesterol deposits | Moderate to high; recurrence is possible |
Non-Surgical Blepharoplasty: Plasma Pen for Eyelid Laxity
The indication with the most widespread clinical use and strongest evidence for plasma pen is upper eyelid laxity. Known as "non-surgical blepharoplasty" or "plasma blepharoplasty," this procedure has become a genuine option for the non-surgical management of mild to moderate lid dermatochalasis.
Ideal patient characteristics:
- Fitzpatrick skin types IβIII (risk of hyperpigmentation increases significantly in darker skin types)
- Laxity attributable solely to excess skin β ptosis due to fat prolapse or levator weakness requires surgery
- Realistic expectations and tolerance for a prolonged recovery period
- No active skin condition, no keloid tendency, no coagulopathy
Technique: After application of a topical anaesthetic cream (EMLA, 45β60 minutes), plasma dots are applied to the eyelid skin at 1β2 mm intervals without overlapping. Dot density and depth are adjusted according to skin thickness and the degree of laxity. Procedure time for the upper eyelids is approximately 30β45 minutes.
Clinical studies have reported an average 30β50% reduction in eyelid skin surface; patient satisfaction scores were high (82β91%) (Journal of Cosmetic and Laser Therapy, 2022).
Skin Tightening with Plasma Pen: Technical Details
The efficacy of plasma pen depends largely on device quality, physician technique and patient selection. Core technical principles include:
- Working distance: The ideal distance between probe and skin is 0.5β2 mm; at this distance, plasma arc formation is controlled. Too close causes broad thermal damage; too far produces insufficient effect.
- Dot density and pattern: Dots must not overlap (each dot has its own healing zone). Standard density is determined using a grid or diamond pattern; high density produces dramatic results but a longer recovery period.
- Energy and frequency settings: The device's wattage and frequency settings vary according to the anatomical region and skin thickness. Thin skin such as the eyelids requires low energy; thicker regions such as the neck require higher energy.
- Cooling and inter-session intervals: Cooling breaks are taken to prevent overheating in large areas. A minimum of 6β8 weeks must elapse between sessions; this interval is mandatory for collagen maturation.
Recovery After Plasma Pen Treatment: What to Expect
The post-treatment course of plasma pen involves a distinct recovery period that must be managed correctly:
| Timeline | Expected Changes | Care Instructions |
|---|---|---|
| Days 1β3 | Pronounced oedema (especially around the eyelids), redness, carbon dots clearly visible | Cold compress (wrapped in cloth), keep head elevated while resting |
| Days 4β7 | Oedema begins to subside, carbon dots form crusts | Do not pick off crusts; use a gentle cleanser and generous moisturiser |
| Days 7β14 | Crusts fall off spontaneously; pink-red base skin visible | SPF 50+ mineral sunscreen; azelaic acid / tranexamic acid for pigmentation |
| Weeks 2β4 | Tightening becomes more noticeable; mild redness may persist | GHK-Cu serum, niacinamide; strict sun protection |
| Months 1β3 | Collagen maturation; results become progressively more evident | Maintain SPF routine; retinoid may be added (after month 1) |
| Months 3β12 | Best results achieved during this period; durability 1β3 years | Annual assessment; maintenance session if required |
Plasma Pen Risks and Complications
Although safe in experienced hands, potential risks of plasma pen treatment include:
- Post-inflammatory hyperpigmentation (PIH): The most common complication. Risk is significantly elevated in Fitzpatrick types IVβVI. Prevention: application of 4% hydroquinone or tranexamic acid for 2β4 weeks prior to treatment; strict sun protection afterwards.
- Hypertrophic scarring or keloid formation: Contraindicated in patients with a history of keloid. This must always be assessed before treatment.
- Ectropion (lower lid eversion): Can develop in lower eyelid applications if excessive thermal damage occurs. Risk is minimised by experienced physician technique.
- Infection: Rare; risk of moist environment and contamination during the crusting phase. Herpes reactivation β prophylactic valacyclovir is recommended prior to treatment.
- Insufficient effect: Results may be unsatisfactory in severe laxity or patients with high expectations. Proper patient selection prevents this.
Plasma Pen vs. Laser: Which Option for Which Situation?
| Feature | Plasma Pen | Ablative Fractional Laser (CO2) |
|---|---|---|
| Skin tightening | Excellent (focal thermal contraction) | Good (thermal coagulation) |
| Surface resurfacing (texture, pores) | Limited | Excellent |
| Eyelid laxity | Excellent (optimal indication) | Moderate |
| Recovery time | 7β14 days (surface), social downtime 5β7 days | 5β10 days (surface), social downtime 7β10 days |
| Safety in darker skin tones | High risk (PIH elevated in Fitzpatrick IVβVI) | High risk; Erbium is safer |
| Cost | Generally lower | Generally higher |
| Lesion treatment (fibromas, etc.) | Excellent (focal ablation) | Moderate |
Patient Selection and Contraindications
Ideal candidate:
- Fitzpatrick types IβIII, medium to fair skin
- Mild to moderate laxity (not requiring surgery)
- Realistic expectations and tolerance for 7β14 days of social downtime
- No active skin condition (no active acne or infection)
Contraindications:
- Active herpes labialis or history of periorbital herpes (without prophylaxis)
- History of keloid or hypertrophic scarring
- Isotretinoin use (within the last 12 months)
- Pregnancy and breastfeeding
- Active autoimmune skin disease (lupus, active vitiligo lesions)
- Cardiac pacemaker or metal implant (near the treatment area)
Plasma Pen Protocol at Virtuana Clinic
At Virtuana Clinic in Kocaeli/Izmit, plasma pen treatments begin with a comprehensive patient assessment. Skin type analysis (using the Fitzpatrick scale), evaluation of the degree of laxity and determination of the appropriate energy protocol are completed before the procedure is planned.
The standard protocol applied at the clinic:
- Pre-procedure: EMLA cream for 30 minutes; sun protection starting 2 weeks prior; prophylactic antiviral therapy for patients with a history of herpes
- During procedure: CE-approved device; standardised dot density template; cooling breaks
- Post-procedure: Written aftercare protocol, restorative care kit (GHK-Cu serum + mineral SPF + moisturiser), follow-up appointments at week 1 and week 4
- Pigmentation management: Pre- and post-treatment support with tranexamic acid mesotherapy for darker skin tones
For pricing information, please contact us.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.